NCT05850078View on ClinicalTrials.gov

FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3)

NAUnknownINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 18, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

August 1, 2024

Conditions
Vaginal Flora Imbalance
Interventions
OTHER

FB101

Intervention will test effects on changes to the vaginal microbiome of FB101 versus diluted FB101 versus placebo

Trial Locations (1)

Unknown

RECRUITING

Atlantia Clinical Trials, Cork

Sponsors
All Listed Sponsors
lead

Freya Biosciences ApS

INDUSTRY